Usefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases

被引:27
|
作者
Yoon S.-H. [1 ]
Kim K.S. [2 ]
Kang S.Y. [3 ]
Song H.-S. [1 ]
Jo K.S. [1 ]
Choi B.-H. [4 ]
Lee S.J. [1 ]
Yoon J.-K. [1 ]
An Y.-S. [1 ]
机构
[1] Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine, San 5, Wonchon-dong, Yeongtong-gu, Suwon, Kyunggi-do
[2] Department of Surgery, Ajou University School of Medicine, San 5, Wonchon-dong, Yeongtong-gu, Suwon, Kyunggi-do
[3] Department of Hematology-Oncology, Ajou University School of Medicine, San 5, Wonchon-dong, Yeongtong-gu, Suwon, Kyunggi-do
[4] Clinical Research Institute, Gyeongsang National University Hospital, Chiram-dong, Jinju Si, Gyeongsangnam-Do
关键词
Breast cancer; PET/CT; Skeletal metastases;
D O I
10.1007/s13139-012-0178-0
中图分类号
学科分类号
摘要
Purpose: Bone metastasis is an important factor for the treatment and prognosis of breast cancer patients. Whole-body bone scintigraphy (WBBS) can evaluate skeletal metastases, and 18F-FDG PET/CT seems to exhibit high specificity and accuracy in detecting bone metastases. However, there is a limitation of 18F-FDG PET in assessing sclerotic bone metastases because some lesions may be undetectable. Recent studies showed that 18F-fluoride PET/CT is more sensitive than WBBS in detecting bone metastases. This study aims to evaluate the usefulness of 18F-fluoride PET/CT by comparing it with WBBS and 18F-FDG PET/CT in breast cancer patients with osteosclerotic skeletal metastases. Materials and Methods: Nine breast cancer patients with suspected bone metastases (9 females; mean age ± SD, 55. 6 ± 10. 0 years) underwent 99mTc-MDP WBBS, 18F-FDG PET/CT and 18F-fluoride PET/CT. Lesion-based analysis of five regions of the skeletons (skull, vertebral column, thoracic cage, pelvic bones and long bones of extremities) and patient-based analysis were performed. Results: 18F-fluoride PET/CT, 18F-FDG PET/CT and WBBS detected 49, 20 and 25 true metastases, respectively. Sensitivity, specificity, positive predictive value and negative predictive value of 18F-fluoride PET/CT were 94. 2 %, 46. 3 %, 57. 7 % and 91. 2 %, respectively. Most true metastatic lesions on 18F-fluoride PET/CT had osteosclerotic change (45/49, 91. 8 %), and only four lesions showed osteolytic change. Most lesions on 18F-FDG PET/CT also demonstrated osteosclerotic change (17/20, 85. 0 %) with three osteolytic lesions. All true metastatic lesions detected on WBBS and 18F-FDG PET/CT were identified on 18F-fluoride PET/CT. Conclusion: 18F-fluoride PET/CT is superior to WBBS or 18F-FDG PET/CT in detecting osteosclerotic metastatic lesions. 18F-fluoride PET/CT might be useful in evaluating osteosclerotic metastases in breast cancer patients. © 2012 Korean Society of Nuclear Medicine.
引用
收藏
页码:27 / 35
页数:8
相关论文
共 50 条
  • [1] Usefulness of 18F-Fluoride PET/CT in Bone Metastasis of Prostate Cancer
    Park, M.
    Kim, J.
    Park, H.
    Kang, C.
    Lim, H.
    Kim, J.
    Lee, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S481 - S481
  • [2] 18F-FDG PET/CT versus 18F-Fluoride PET/CT for Detecting Bone Metastases in Patients With Breast Cancer and Equivocal Bone Scan
    Brito, A. E.
    Almeida, R. G.
    Mosci, C.
    Lima, M. C. L.
    Amorim, B. J.
    Santos, A. O.
    Souza, T. F.
    Brunetto, S. Q.
    Etchebehere, E. C.
    Ramos, C. D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S273 - S274
  • [3] Kinetic Analysis of 18F-Fluoride PET Images of Breast Cancer Bone Metastases
    Doot, Robert K.
    Muzi, Mark
    Peterson, Lanell M.
    Schubert, Erin K.
    Gralow, Julie R.
    Specht, Jennifer M.
    Mankoff, David A.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 521 - 527
  • [4] Clinical usefulness of 18F-fluoride bone PET
    Kang J.Y.
    Lee W.W.
    So Y.
    Lee B.C.
    Kim S.E.
    [J]. Nuclear Medicine and Molecular Imaging, 2010, 44 (1) : 55 - 61
  • [5] Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?
    Azad, Gurdip K.
    Siddique, Musib
    Taylor, Benjamin
    Green, Adrian
    O'Doherty, Jim
    Gariani, Joanna
    Blake, Glen M.
    Mansi, Janine
    Goh, Vicky
    Cook, Gary J. R.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) : 322 - 327
  • [6] 18F-Fluoride PET/CT for detection of bone metastases in patients with renal cell carcinoma
    Sharma, Punit
    Karunanithi, Sellam
    Chakroborty, Partha
    Kumar, Rajeev
    Bal, Chandrasekhar
    Kumar, Rakesh
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [7] Serial FDG and 18F-fluoride PET predict response to therapy in patients with breast cancer bone metastases
    Montgomery, S. K.
    Barlow, W. E.
    Linden, H. M.
    Gralow, J. R.
    Ellis, G. K.
    Gadi, V. K.
    Schubert, E. K.
    Peterson, L. M.
    Novakova, A.
    Doot, R.
    Dunnwald, L. K.
    Mankoff, D. A.
    Specht, J. M.
    [J]. CANCER RESEARCH, 2013, 73
  • [8] 18F-Fluoride PET/CT in patients with equivocal bone scintigraphy
    Bortot, D. C.
    Oki, G. C. R.
    Amorim, B. J.
    Gapski, S. B.
    Ruiz, P. P. G.
    Arouca, P. T.
    Santos, A. O.
    Lima, M. C. L.
    Etchebehere, E. C. S. C.
    Camargo, E. E.
    Barbosa, M. F.
    Menguatti, J.
    Ramos, C. D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S353 - S353
  • [9] Comparison of 18F-fluoride PET/CT, 18F-FDG PET/CT, and bone scintigraphy in detection of bone metastases of differentiated thyroid cancer
    Ota, N.
    Kato, K.
    Iwano, S.
    Ito, S.
    Tsuchiya, K.
    Okochi, Y.
    Okada, Y.
    Naganawa, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S383 - S383
  • [10] Reproducibility of quantitative parameters of 18F-Fluoride PET/CT in prostate bone metastases
    Wassberg, C.
    Sorensen, J.
    Lubberink, M.
    Johansson, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S242 - S242